BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

NexGenix Pharmaceuticals Holdings, Inc. 

Headquarters:
152 West 57th Street, Suite 11B
New York, New York 10019 U.S.A.

Phone: 212-974-3006 Fax: 212-974-1042

Laboratory:
849 Mitten Road, Suite 104

Burlingame  California  94010  U.S.A.
Phone: 650-697-8500 Fax: 650-697-8530


SEARCH JOBS


Industry
Pharmaceutical






 Company News
Provence Technologies and NexGenix Pharmaceuticals Holdings, Inc. Announce Successful Lead Compound Development 6/27/2011 12:34:34 PM    More...
NexGenix Pharmaceuticals Holdings, Inc. Release: US Patent Granted for a New Family of Heat Shock Protein 90 (Hsp90) Inhibitors for the Treatment of Cancer and Neurodegenerative Indications 5/20/2011 7:08:27 AM    More...
NexGenix Pharmaceuticals Holdings, Inc. Awarded Phase I Grant from the National Institute of Neurological Disorders and Stroke 10/22/2009 11:08:36 AM    More...
NexGenix Pharmaceuticals Holdings, Inc. Presents Data on a Novel Small Molecule Inhibitor of Heat Shock Protein 90 (Hsp90) 4/17/2008 7:54:35 AM    More...
NexGenix Pharmaceuticals Holdings, Inc. Presents Data on a Novel Small Molecule Inhibitor of Heat Shock Protein 90 (Hsp90) at the GTCbio Cancer Drugs Research & Development Conference 2/25/2008 6:44:35 AM    More...
NexGenix Pharmaceuticals Holdings, Inc. Enters into Exclusive World-wide License to Develop Novel Hsp90 Inhibitors 9/26/2007 10:16:14 AM    More...
NexGenix Pharmaceuticals Holdings, Inc. Closes $3.9M Round of Financing 7/13/2007 9:19:36 AM    More...
NexGenix Pharmaceuticals, LLC To Present At Rodman & Renshaw 8th Annual Healthcare Conference 10/24/2006 12:04:05 PM    More...
NexGenix Pharmaceuticals, LLC Announces Key Personnel Appointments As It Prepares To Enter Clinical Trials In The US 9/25/2006 1:19:21 PM    More...
NexGenix Pharmaceuticals, LLC To Present At Biotechnology Industry Organization (BIO) VentureForum East 2006 5/23/2006 10:54:09 AM    More...

//-->